Mon.Apr 27, 2020

article thumbnail

Has COVID-19 Become the Catalyst for Virtual Clinical Trials?

Crucial Data Soutions

The COVID-19 pandemic that struck the globe this year has drastically disrupted the state of affairs in the life sciences industry. Traditional methods of clinical data collection and trial management encountered change in mid-March as the FDA released guidance on conducting trials during the pandemic. In the guidance, the FDA emphasizes the importance of curtailing risk and further ensuring patient safety, and makes recommendations such as implementing a centralized or remote monitoring program